|
GB445289A
(en)
*
|
1934-10-04 |
1936-04-06 |
Karl Merck |
manufacture of stabilised preparations of divinyl ether
|
|
US3097133A
(en)
*
|
1959-12-21 |
1963-07-09 |
Ici Ltd |
Anaesthetic 1: 1: 1: 3: 3: 3-hexafluoro-2-halopropane
|
|
BE786675A
(fr)
|
1971-08-02 |
1973-01-25 |
Airco Inc |
Separation d'oxydes d'alkyle halogenes par distillation azeotropique.
|
|
US4109651A
(en)
|
1975-11-19 |
1978-08-29 |
Steigerwald Allan M |
Anesthetic gas exhaust system
|
|
US4954487A
(en)
*
|
1979-01-08 |
1990-09-04 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions
|
|
US4453951A
(en)
|
1980-07-09 |
1984-06-12 |
General Electric Co. |
Process for the production of silicone carbide composite
|
|
SE8008962L
(sv)
|
1980-12-18 |
1982-06-19 |
Erik Allan Lindkvist |
Anordning vid narkosmask
|
|
US4879062A
(en)
|
1981-10-20 |
1989-11-07 |
Adamantech, Inc. |
Preparation of a gel having gas transporting capability
|
|
US4622219A
(en)
*
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
|
US4744989A
(en)
|
1984-02-08 |
1988-05-17 |
E. R. Squibb & Sons, Inc. |
Method of preparing liposomes and products produced thereby
|
|
US4837163A
(en)
*
|
1987-10-02 |
1989-06-06 |
Tsuyoshi Ohnishi |
Simple blood test for diagnosing malignant hyperthermia
|
|
US4994025A
(en)
*
|
1989-08-29 |
1991-02-19 |
Baxter International Inc. |
Method of dissolving cholesterol-rich calculi with short chain halogenated organic solvents and cosolvents
|
|
US5466468A
(en)
|
1990-04-03 |
1995-11-14 |
Ciba-Geigy Corporation |
Parenterally administrable liposome formulation comprising synthetic lipids
|
|
US5677290A
(en)
|
1990-05-10 |
1997-10-14 |
Fukunaga; Atsuo F. |
Therapeutic use of adenosine compounds as surgical anesthetics
|
|
US5679650A
(en)
|
1993-11-24 |
1997-10-21 |
Fukunaga; Atsuo F. |
Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
|
|
US5114714A
(en)
|
1990-11-29 |
1992-05-19 |
Sepracor, Inc. |
Methods of use and compositions of (r)-isoflurane and (r)-desflurane
|
|
DE4105972C2
(de)
|
1991-02-26 |
1999-06-02 |
Draegerwerk Ag |
Narkosemitteldosiervorrichtung
|
|
BE1005163A3
(fr)
|
1991-08-01 |
1993-05-11 |
Solvay |
Compositions contenant un ether fluore et utilisation de ces compositions.
|
|
GB9202238D0
(en)
|
1992-02-03 |
1992-03-18 |
Wellcome Found |
Compounds
|
|
US5230778A
(en)
|
1992-05-01 |
1993-07-27 |
Gavlin Associates |
Purification of isoflurane by extractive distillation
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
GB9308306D0
(en)
|
1993-04-22 |
1993-06-09 |
Univ Aberdeen |
Analgesic composition
|
|
GB9312578D0
(en)
*
|
1993-06-18 |
1993-08-04 |
Isis Innovation |
Determining gas concentration
|
|
PT711289E
(pt)
|
1993-07-30 |
2001-02-28 |
Delta Pharmaceuticals Inc |
Compostos piperazina utilizados em terapia
|
|
GB9423542D0
(en)
|
1994-11-22 |
1995-01-11 |
Marples Brian A |
Pharmaceutical compounds
|
|
US5563153A
(en)
*
|
1995-02-22 |
1996-10-08 |
University Of Kansas Medical Center |
Sterile topical anesthetic gel
|
|
US5568910A
(en)
|
1995-03-02 |
1996-10-29 |
Delmarva Laboratories, Inc. |
Anesthesia machine
|
|
US6248788B1
(en)
|
1996-11-06 |
2001-06-19 |
The Regents Of The University Of California |
Therapeutic method with capsaicin and capasicin analogs
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
US5861175A
(en)
*
|
1996-03-15 |
1999-01-19 |
Alliance Pharmaceutical Corp. |
Use of fluorocarbons for diagnosis and treatment of articular disorders
|
|
US5919826A
(en)
|
1996-10-24 |
1999-07-06 |
Algos Pharmaceutical Corporation |
Method of alleviating pain
|
|
US5990176A
(en)
*
|
1997-01-27 |
1999-11-23 |
Abbott Laboratories |
Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
|
|
US20030212123A1
(en)
|
1997-05-05 |
2003-11-13 |
Pfizer Inc. |
COX-2 selective carprofen for treating pain and inflammation in dogs
|
|
CA2288828A1
(en)
|
1997-07-14 |
1999-01-28 |
Adolor Corporation |
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
|
|
US20030185761A1
(en)
*
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
|
US5976072A
(en)
|
1998-01-29 |
1999-11-02 |
Johns Hopkins University |
Copa method for fiberoptic endotracheal intubation
|
|
AR015744A1
(es)
|
1998-04-01 |
2001-05-16 |
Orion Corp |
Uso de dexmedetomidina para sedacion en terapia intensiva
|
|
US6830581B2
(en)
|
1999-02-09 |
2004-12-14 |
Innercool Therspies, Inc. |
Method and device for patient temperature control employing optimized rewarming
|
|
US6869440B2
(en)
|
1999-02-09 |
2005-03-22 |
Innercool Therapies, Inc. |
Method and apparatus for patient temperature control employing administration of anti-shivering agents
|
|
ES2267546T3
(es)
*
|
1999-06-10 |
2007-03-16 |
Bridge Pharma, Inc. |
Agentes anestesicos dermicos.
|
|
US6706034B1
(en)
|
1999-12-30 |
2004-03-16 |
Advanced Cardiovascular Systems, Inc. |
Process for agent retention in biological tissues
|
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
|
AU2001254625B2
(en)
|
2000-05-02 |
2006-02-02 |
Action Pharma A/S |
Use of alpha-MSH and EPO for preventing or treating ischemic conditions
|
|
US6770636B2
(en)
|
2000-08-18 |
2004-08-03 |
Boehringer Ingelheim Pharma Kg |
Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines
|
|
US20030152637A1
(en)
*
|
2001-01-25 |
2003-08-14 |
Mark Chasin |
Local anesthetic, and method of use
|
|
AU2002256359A1
(en)
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Antisense and anti-inflammatory based compositions to treat respiratory disorders
|
|
MXPA04006572A
(es)
|
2002-01-10 |
2005-11-04 |
Upjohn Co |
Terapia de combinacion antivirica.
|
|
US20030181426A1
(en)
|
2002-02-11 |
2003-09-25 |
Eisenach James C. |
Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
|
|
AU2003219167A1
(en)
|
2002-03-19 |
2003-09-29 |
Genset Sa |
Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists
|
|
ES2346868T3
(es)
|
2002-08-10 |
2010-10-21 |
Yale University |
Antagonistas de receptor nogo.
|
|
CA2500310C
(en)
*
|
2002-10-11 |
2013-03-12 |
Baxter International, Inc. |
Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
|
|
NZ542690A
(en)
|
2003-03-28 |
2009-04-30 |
Acadia Pharm Inc |
Muscarinic M1 receptor agonists for pain management
|
|
WO2004100868A2
(en)
|
2003-04-23 |
2004-11-25 |
Abbott Laboratories |
Method of treating transplant rejection
|
|
US20030173287A1
(en)
|
2003-05-06 |
2003-09-18 |
Johnston Arthur W |
Filter devices and methods of use
|
|
EP1631234B1
(en)
|
2003-05-16 |
2011-09-14 |
Acorda Therapeutics, Inc. |
Compositions and methods for the treatment of cns injuries
|
|
BRPI0413426A
(pt)
|
2003-08-07 |
2006-10-17 |
Biogen Idec Inc |
antagonistas de receptor novo
|
|
ATE395052T1
(de)
|
2003-08-15 |
2008-05-15 |
Ab Science |
Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
|
|
DE602004015142D1
(de)
|
2003-08-29 |
2008-08-28 |
Childrens Medical Center |
Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
|
|
ATE365034T1
(de)
*
|
2003-09-10 |
2007-07-15 |
Cristalia Prod Quimicos Farm |
Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung
|
|
BR0303489A
(pt)
*
|
2003-09-10 |
2005-07-05 |
Cristalia Prod Quimicos Farm |
Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
|
|
KR20060088885A
(ko)
|
2003-09-25 |
2006-08-07 |
아카디아 파마슈티칼스 인코포레이티드 |
뉴로펩티드 ｆｆ 리셉터 2의 작용제를 이용한 신경병증성통증 치료 방법
|
|
US20070053963A1
(en)
*
|
2004-01-13 |
2007-03-08 |
Hotchkiss Robert N |
Drug delivery to a joint
|
|
US20060051413A1
(en)
*
|
2004-09-08 |
2006-03-09 |
Chow Sing S M |
Method of enhancing absorptions of transmucosal administration formulations
|
|
US8557861B2
(en)
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
US20060198891A1
(en)
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
|
WO2007070694A2
(en)
*
|
2005-12-14 |
2007-06-21 |
Zars, Inc. |
Spray-on formulations and methods for dermal delivery of drugs
|
|
US8791163B2
(en)
*
|
2006-01-13 |
2014-07-29 |
Mcgill University |
Melatonin ligands having antidepressant activity as well as sleep inducing properties
|
|
ES2535233T3
(es)
*
|
2006-01-25 |
2015-05-06 |
Insys Therapeutics, Inc. |
Pulverización de fentanilo sublingual
|
|
CA2663857C
(en)
|
2006-09-20 |
2017-10-31 |
The Board Of Regents Of The University Of Texas System |
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
|
|
EP2099408B1
(en)
|
2006-11-28 |
2016-10-05 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
|
EP2244783B1
(en)
|
2008-01-22 |
2019-12-18 |
Board Of Regents, The University Of Texas System |
Volatile anesthetic compositions and methods of use
|
|
CN109394689A
(zh)
|
2009-05-05 |
2019-03-01 |
德州大学系统董事会 |
挥发性麻醉剂的新型制剂及其用于减轻炎症的使用方法
|